Managing endothelial dysfunction in <scp>COVID</scp> ‐19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, <scp>double‐blind</scp> , <scp>placebo‐controlled</scp> , randomized clinical trial-Reference-Cited by-同舟云学术

Managing endothelial dysfunction in COVID ‐19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double‐blind , placebo‐controlled , randomized clinical trial

Published:2022-07-20 Issue:10 Volume:15 Page:2323-2330
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Matli Kamal¹²,Al Kotob Abdulrahman³,Jamaleddine Wassim³^ORCID,Al Osta Soad³⁴,Salameh Pascale⁴⁵⁶⁷,Tabbikha Rami³,Chamoun Nibal⁸,Moussawi Ahmad³,Saad Jean‐Michel³,Atwi Gibran³⁴,Saad Tarik Abu¹,Jamal Omar³,Mokhbat Jacques³,Ghanem Georges¹

Affiliation:

1. Cardiology Department Lebanese American University Medical Center – Rizk Hospital Beirut Lebanon

2. Service de Cardiologie Centre Hospitalier de Haguenau Haguenau France

3. Department of Internal Medicine Lebanese American University Medical Center – Rizk Hospital Beirut Lebanon

4. School of Medicine, Lebanese American University Byblos Lebanon

5. Faculty of Pharmacy Lebanese University Hadat Lebanon

6. Institut National de Santé Publique d'Epidémiologie Clinique et Toxicologie – Liban (INSPECT‐LB) Beirut Lebanon

7. Department of Primary Care and Population Health University of Nicosia Medical School Nicosia Cyprus

8. Department of Pharmacy Practice Lebanese American University School of Pharmacy Byblos Lebanon

Funder

Lebanese American University

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13369

Reference20 articles.

1. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19

2. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19

3. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science

4. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review

5. Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital;Hypertension Research;2024-04-26

2. Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study;Frontiers in Pharmacology;2023-12-05

3. Latest development of approved COVID-19 drugs and COVID-19 drugs undergoing late stage clinical trials;Frontiers in Drug Discovery;2023-12-01

4. Prior Statin vs In-Hospital Statin Usage in Severe COVID-19: Review and Meta-Analysis;Current Problems in Cardiology;2023-09

5. Statins in hospitalized COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials;Journal of Medical Virology;2023-05-31